Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon Herschhorn

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
ACS Infectious Diseases|December 13, 2022
Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies <i>In Vivo</i>Alon Herschhorn
Mbio|December 8, 2023
Ultrasensitive quantification of HIV-1 cell-to-cell transmission in primary human CD4<sup>+</sup> T cells measures viral sensitivity to broadly neutralizing antibodiesDmitriy Mazurov, Alon Herschhorn
Journal of Medicinal Chemistry|September 20, 2008
Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1Alon Herschhorn, Amnon Hizi
Cellular and Molecular Life Sciences : CMLS|April 2, 2010
Retroviral reverse transcriptasesAlon Herschhorn, Amnon Hizi
Trends in Molecular Medicine|June 18, 2024
Insights from HIV-1 vaccine and passive immunization efficacy trialsShamim Ahmed, Alon Herschhorn
Receptors & Clinical Investigation|July 29, 2017
An entry-competent intermediate state of the HIV-1 envelope glycoproteinsAlon Herschhorn, Joseph Sodroski
Virus Research|February 23, 2008
Retroviral reverse transcriptases (other than those of HIV-1 and murine leukemia virus): a comparison of their molecular and biochemical propertiesAmnon Hizi, Alon Herschhorn
Clinical Microbiology Reviews|July 17, 2024
mRNA-based HIV-1 vaccinesShamim Ahmed, Alon Herschhorn
ACS Infectious Diseases|June 3, 2021
Science at Its Best in the Time of the COVID-19 PandemicAlon Herschhorn, Ashley T Haase
Biochimica Et Biophysica Acta|May 22, 2003
Recombinant human antibodies against the reverse transcriptase of human immunodeficiency virus type-1Alon Herschhorn, Arie Admon, Amnon Hizi
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
ACS Infectious Diseases|December 13, 2022
Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies <i>In Vivo</i>Alon Herschhorn
Mbio|December 8, 2023
Ultrasensitive quantification of HIV-1 cell-to-cell transmission in primary human CD4<sup>+</sup> T cells measures viral sensitivity to broadly neutralizing antibodiesDmitriy Mazurov, Alon Herschhorn
Journal of Medicinal Chemistry|September 20, 2008
Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1Alon Herschhorn, Amnon Hizi
Cellular and Molecular Life Sciences : CMLS|April 2, 2010
Retroviral reverse transcriptasesAlon Herschhorn, Amnon Hizi
Trends in Molecular Medicine|June 18, 2024
Insights from HIV-1 vaccine and passive immunization efficacy trialsShamim Ahmed, Alon Herschhorn
Receptors & Clinical Investigation|July 29, 2017
An entry-competent intermediate state of the HIV-1 envelope glycoproteinsAlon Herschhorn, Joseph Sodroski
Virus Research|February 23, 2008
Retroviral reverse transcriptases (other than those of HIV-1 and murine leukemia virus): a comparison of their molecular and biochemical propertiesAmnon Hizi, Alon Herschhorn
Clinical Microbiology Reviews|July 17, 2024
mRNA-based HIV-1 vaccinesShamim Ahmed, Alon Herschhorn
ACS Infectious Diseases|June 3, 2021
Science at Its Best in the Time of the COVID-19 PandemicAlon Herschhorn, Ashley T Haase
Biochimica Et Biophysica Acta|May 22, 2003
Recombinant human antibodies against the reverse transcriptase of human immunodeficiency virus type-1Alon Herschhorn, Arie Admon, Amnon Hizi
Pageof 7